Emtricitabine and tenofovir disoproxil fumarate 300 mg/1 (Emtricitabine and tenofovir disoproxil fumarate TABLET, FILM COATED) 300 mg/1

Emtricitabine and tenofovir disoproxil fumarate 300 mg/1 tablets are a combination medication used to manage HIV infection. This oral treatment is designed to support HIV management as part of a comprehensive regimen.

Strength

300 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (31722-560-30)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Emtricitabine and tenofovir disoproxil fumarate 300 mg/1 tablets are primarily used in the management of HIV infection. This combination therapy is intended to help control the virus and improve immune function. The medication works by inhibiting the replication of the HIV virus, which can help reduce the viral load in the body. It is often used as part of a broader treatment plan that includes other medications and lifestyle adjustments.

Side Effects

Common effects of emtricitabine and tenofovir disoproxil fumarate 300 mg/1 tablets may include nausea, diarrhea, and headache. Some individuals might experience dizziness or fatigue. These effects can vary in intensity and duration. It is important to monitor any persistent or severe symptoms and consult a healthcare provider if necessary.

Precautions & Warnings

Emtricitabine and tenofovir disoproxil fumarate 300 mg/1 tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight and out of reach of children. Always follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not share this medication with others, even if they have similar symptoms.

Avoid Interactions

Emtricitabine and tenofovir disoproxil fumarate 300 mg/1 tablets may interact with other medications, including certain antibiotics, antifungals, and anticonvulsants. Alcohol consumption should be avoided while taking this medication, as it can exacerbate side effects. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Emtricitabine and tenofovir disoproxil fumarate is used to manage HIV infection by inhibiting the replication of the virus.

Take emtricitabine and tenofovir disoproxil fumarate 300 mg/1 tablets orally, typically once daily, as directed by your healthcare provider.

Common side effects may include nausea, diarrhea, headache, dizziness, and fatigue.

It is generally advised to avoid alcohol while taking emtricitabine and tenofovir disoproxil fumarate, as it can worsen side effects.

Store emtricitabine and tenofovir disoproxil fumarate tablets in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.